Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Draxis Health Inc. (NasdaqNM:DRAX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Reports
Location
6870 Goreway Drive, Ontario L4V 1P1
Mississauga, Canada
Phone: (905) 677-5500
Fax: (905) 677-5502
Email: plee@draxis.com
Employees (last reported count): 28
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 18%
·Institutional: 6% (7% of float)
(12 institutions)
·Net Inst. Selling: 473.0K shares (+27.25%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Draxis Health Inc. is a diversified specialty pharmaceutical company with operations in four niche markets: radiopharmaceuticals through DRAXIMAGE Inc.; contract manufacturing through DRAXIS Pharma Inc.; Canadian pharmaceutical sales and marketing through DRAXIS Pharmaceutica, and companion animal health through Deprenyl Animal Health, Inc. and its global alliance with Pfizer Inc., with respect to Anipryl. The Company is emerging from a transitional phase of its development and, as of December 31, 2000, it has been reliant on income earned from Anipryl. DRAXIMAGE discovers, develops, manufactures and markets diagnostic imaging and therapeutic radiopharmaceuticals for the global marketplace. Its products can be divided into radioactive products, which are in a radioactive and ready-to-use form when shipped to customers, and non-radioactive products, which are sold in lyophilised (freeze-dried), non-radioactive form.
More from Market Guide: Expanded Business Description

Financial Summary
Draxis Health Inc. is a diversified pharmaceutical company with operations in three niche businesses: Veterinary, Radiopharmaceuticals and Canadian Pharmaceutical Marketing. For the six months ended 6/30/01, revenues rose 12% to $19.7 million. Net loss before accounting change totalled $2.5 million vs. income of $401 thousand. Revenues reflect higher sales in the Manufacturing and Companion Animal Health segments. Loss reflects increased depreciation and amortization costs.
More from Market Guide: Significant Developments

Officers
FY1999 Compensation
PayExer

Brian King
Chairman
--  --  
Martin Barkin, M.D.
Pres and CEO
$545K$54K
James Doherty
Vice Chairman
--  --  
Dan Brazier
Pres, Draxis Pharmaceutica
230K--  
Raymond Dore
Pres, DRAXIMAGE Inc.
--  --  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:DRAXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 10-Apr-2001
$1.50 
Recent Price$2.05 
52-Week High
on 21-Sep-2000
$3.75 
Beta0.59 
Daily Volume (3-month avg)92.7K
Daily Volume (10-day avg)28.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-29.5%
52-Week Change
relative to S&P500
-5.4%
Share-Related Items
Market Capitalization$75.0M
Shares Outstanding36.6M
Float30.0M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.59 
Earnings (ttm)-$0.60 
Earnings (mrq)-$0.07 
Sales (ttm)$1.02 
Cash (mrq)$0.12 
Valuation Ratios
Price/Book (mrq)3.46 
Price/EarningsN/A 
Price/Sales (ttm)2.02 
Income Statements
Sales (ttm)$37.1M
EBITDA (ttm)$3.32M
Income available to common (ttm)-$21.9M
Profitability
Profit Margin (ttm)-15.0%
Operating Margin (ttm)-3.0%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-7.82%
Return on Equity (ttm)-73.09%
Financial Strength
Current Ratio (mrq)1.29 
Debt/Equity (mrq)0.54 
Total Cash (mrq)$4.28M
Short Interest
As of 8-Aug-2001
Shares Short3,000 
Percent of Float0.0%
Shares Short
(Prior Month)
0 
Short Ratio0.04 
Daily Volume71.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.